comparemela.com

Latest Breaking News On - Robert dreicer - Page 1 : comparemela.com

Dr Dreicer on the Different Approaches to mCRPC Management

Robert Dreicer, MD, discusses different approaches in prostate cancer management according to the type of oncologist.

Robert dreicerDivision of hematology oncologyUniversity of virginia cancer centerVirginia cancer centerProstate cancer management

Looking Beyond PSA Is Key to Understanding Nuances of Prostate Cancer Treatment

Robert Dreicer, MD, discusses the complex landscape of prostate cancer treatment, highlighting key points from his presentation at the 2024 NY GU.

Robert dreicerNational comprehensive cancer networkDivision of hematology oncologyInterdisciplinary prostate cancer congressUniversity of virginia cancer centerAnnual interdisciplinary prostate cancer congressVirginia cancer centerHormone sensitive metastatic prostate

Dr Dreicer on Improving Clinical Trial Design in Prostate Cancer

Robert Dreicer, MD, discusses the shortcomings of current clinical trials in prostate cancer and what he sees as the biggest area of improvement.

Robert dreicerDivision of hematology oncologyUniversity of virginia cancer centerNational comprehensive cancer networkVirginia cancer centerClinical oncology

In Advanced Prostate Cancer, a String of Modest Gains Are Changing Patient Care

Robert Dreicer, MD, MS, MACP, FASCO, acknowledges that there have been substantial developments in therapies and strategies for treating prostate cancer, leading to heightened expectations of breakthroughs in the field.

United statesSalt lake cityNeeraj agarwalRobert dreicerUtah huntsman cancer institute centerDrug administrationUniversity of virginia school medicineInvestigational therapeutics genitourinary oncology programUniversity of utah huntsman cancer instituteVirginia schoolLake cityHuntsman cancer instituteInvestigational therapeuticsGenitourinary oncology programAccessed julyPlus abiraterone

Did the Decline in PSA Testing Lead to More Cases of Advanced Prostate Cancer?

FRIDAY, Oct. 28, 2022 (HealthDay News) A large new study of U.S. veterans suggests that when prostate cancer screening rates go down, the number of men diagnosed with advanced

United statesLong islandSan antonioAnthony corcoranRobert dreicerAlex bryantUniversity of virginia cancer centerAmerican society for radiation oncologyAmerican society of clinical oncologyUs preventive services task forceUniversity of michigan rogel cancer centerAmerican cancer societyHealthday newsAmerican cancerServices task forceMichigan rogel cancer center

vimarsana © 2020. All Rights Reserved.